ICYMI, some of this week’s featured content includes a new podcast episode, video interviews about FDA delays and sunscreen recalls, articles on topline study results for alopecia areata and utilizing the psoriasis toolbox, plus more.
A study published in the Journal of the American Academy of Dermatology examined the potential relationship between air pollution and the incidence of atopic dermatitis.
Due to the multimorbid nature of the disease, clinicians must screen, monitor, and aggressively treat the associated comorbidities.
Novel inhibitor of the 26S proteasome was found to be safe, well-tolerated, and effective in reducing inflammatory lesions and erythema in patients with rosacea.
Eli Lilly announced that lebrikizumab has met all primary and key secondary endpoints at week 16 in their 2 phase 3 trials.
A study published in JAMA Dermatology investigated the strain acne puts on the lives of adult women.
Ideal Image has announced the launch of its new affiliate program to help expand its national point of care network.
In this exclusive video interview, David Prokupek, CEO, Ideal Image, sits down with Dermatology Times to discuss the company's new affiliate program aimed at expanding its national point of care network.
Jason Emer, MD, in this video interview, discusses plasma pen cosmetic treatments, the influx of patient interest, dangers of non-FDA cleared pens, and how to work with SOC patients.
A recent study investigated the difference between skin microbiota in patients with acne and controls without acne.
In this episode, Jennifer Powers, MD, board certified dermatologist and associate professor of dermatology at the University of Iowa, discusses her recent research exploring how diet and supplements affect patients with mild psoriasis.
This week’s edition of The Mainstream Patient features stories about psoriasis, pityriasis rosea, microcurrent facials, preventative Botox, plus more.
The development and implementation of quality improvement (QI) programs can positively impact patient care and outcomes. As such, it behooves physicians to research and implement QI practice initiatives and measures in their practice.
A pilot study from the Journal of Cosmetic Dermatology investigated the efficacy and tolerability of a comprehensive antioxidant treatment for male patients seeking skin improvement.